NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note
1 — Basis of Presentation
GlassBridge
Enterprises, Inc. (“GlassBridge”, the “Company”, “we”, “us” or “our”) owns
and operates an asset management business through various subsidiaries.
The
interim Condensed Consolidated Financial Statements of GlassBridge are unaudited but, in the opinion of management, reflect all adjustments
necessary for a fair statement of financial position, results of operations, comprehensive loss and cash flows for the periods presented.
Except as otherwise disclosed herein, these adjustments consist of normal and recurring items. The results of operations for any interim
period are not necessarily indicative of full year results. The Condensed Consolidated Financial Statements and Notes are presented in
accordance with the requirements for Quarterly Reports on Form 10-Q and do not contain certain information included in our annual Consolidated
Financial Statements and Notes presented in accordance with the requirements of Annual Reports on Form 10-K.
The
interim Condensed Consolidated Financial Statements include the accounts of the Company, its wholly-owned subsidiaries, and entities
in which the Company owns or controls fifty percent or more of the voting shares or interest in such entity, and has the right to control.
The results of entities disposed of are included in the unaudited Condensed Consolidated Financial Statements up to the date of the disposal
and, where appropriate, these operations have been reflected as discontinued operations. All inter-company balances and transactions
have been eliminated in consolidation and, in the opinion of management, all adjustments necessary for a fair presentation have been
included in the interim results reported.
The
preparation of the interim Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in
the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim Condensed Consolidated Financial
Statements and the reported amounts of revenue and expenses for the reporting periods. Despite our intention to establish accurate estimates
and use reasonable assumptions, actual results may differ from our estimates.
The
December 31, 2022 Condensed Consolidated Balance Sheet data were derived from the audited Consolidated Financial Statements, but do not
include all disclosures required by GAAP. This Form 10-Q should be read in conjunction with our Consolidated Financial Statements and
Notes included in our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the U.S. Securities and Exchange
Commission on April 7, 2023.
Note
2 — New Accounting Pronouncements
The
Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting
Standards Board (“FASB”). The Company has implemented all new accounting pronouncements that are in effect. These pronouncements
did not have any material impact on the consolidated financial statements unless otherwise disclosed, and the Company does not believe
that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position
or results of operations.
Note
3 —Income (Loss) per Common Share
Basic
income per common share is calculated using the weighted average number of shares outstanding for the period. Unvested restricted stock
and treasury shares are excluded from the calculation of weighted average number of common shares outstanding in all cases. Once restricted
stock vests, it is included in our common shares outstanding.
Diluted
income per common share is computed on the basis of the weighted average shares outstanding plus the dilutive effect of our stock-based
compensation plans, using the “treasury stock” method.
The
Company has 1,360 shares of outstanding and exercisable stock options that have been excluded because they would be anti-dilutive. See
Note 7 –Stock-Based Compensation for additional information on the stock options.
The
following table sets forth the computation of weighted average basic and diluted income per share (unaudited):
Schedule of Computation of Weighted Average Basic and Diluted Income (Loss) Per Share
(Dollars in millions, except for per share amounts) | |
2023 | | |
2022 | |
| |
Three Months Ended | |
| |
March 31, | |
(Dollars in millions, except for per share amounts) | |
2023 | | |
2022 | |
Numerator: | |
| | | |
| | |
Net loss available for common stockholders | |
$ | (1.1 | ) | |
$ | (0.8 | ) |
Denominator: | |
| | | |
| | |
Weighted average number of common shares outstanding during the period - basic and diluted (in thousands) | |
| 26.4 | | |
| 26.4 | |
| |
| | | |
| | |
Net loss per common share – basic and diluted | |
$ | (41.67 | ) | |
$ | (30.30 | ) |
Note
4 — Supplemental Balance Sheet Information
Additional
supplemental balance sheet information is provided as follows:
Other
current assets were $0.3 million and $0.0 million as of March 31, 2023 and December 31, 2022, respectively.
Other
current liabilities were $0.4 million as of March 31, 2023 and December 31, 2022, and include accruals for payroll expense of $0.2 million
and insurance and corporate liability accruals of $0.2 million.
Note
5 — Arrive Investment
Arrive
LLC (“Arrive”) is a company that was formed in partnership with Roc Nation with the intent of building a new platform and
brand focused on early stage, high growth opportunities. Roc Nation is a full-service entertainment company, inclusive of artist and
athlete management, label, publishing, touring, film/TV and new ventures. Arrive seeks to leverage these relationships to invest in proprietary
opportunities and provide services including, but not limited to, marketing, promotion or strategic advice for its portfolio investments.
The Company holds two separate Arrive investments described below.
| ● | Investment
in Arrive of $12.5 million and $12.8 million as of March 31, 2023 and December 31, 2021,
respectively, represents an investment in the Arrive operating company, Arrive I LLC. The
Company’s investment entitles the Company to appoint one of five Arrive Board members
and gives the Company priority for distributions of current income and investment proceeds.
In addition, the Company is entitled to receive between 18% and 20% of all general partner
consideration on pooled investment vehicles managed by Arrive, whether characterized as management
fees or incentive fees. |
| ● | Other
assets of $0.6 million and $0.5 million as of March 31, 2023 and December 31, 2022, respectively,
represent an investment in the Arrive Opportunities Fund I, LP, managed by an affiliate of
Arrive I LLC. |
The
Company did not record any unrealized gains or losses during the three months ended March 31, 2023 or 2022 related to these investments.
The Company took a distribution of $0.3 million from the Arrive operating company, Arrive I LLC, in the form of marketable securities
during the three months ended, March 31, 2023. The Company is not required to contribute additional capital to either of the investments.
Historically,
the Company accounted for such investments under the cost method of accounting. The adoption of ASU No. 2016-01 in the first quarter
of 2018 effectively eliminated the cost method of accounting, and the carrying value of this investment is written down, or impaired,
to fair value when a decline in value is considered to be other-than-temporary. Our strategic investment in equity securities does not
have a readily determinable fair value; therefore, the new guidance was adopted prospectively. As of March 31, 2023, there were no indicators
of impairment for this investment. The Company will assess the investment for potential impairment, quarterly.
Note
6 — Debt
Debt
and notes payable consists of the following:
Schedule
of Debt and Notes Payable
| |
| | |
| |
| |
March 31, | | |
| |
| |
2023 | | |
December 31, | |
| |
(unaudited) | | |
2022 | |
| |
(in millions) | |
GHI LLC note payable | |
$ | 3.8 | | |
$ | 3.7 | |
Other liabilities | |
| 0.2 | | |
| 0.2 | |
Total long term debt | |
$ | 4.0 | | |
$ | 3.9 | |
The
Company entered into a Term Loan and Security Agreement (“GHI Loan Agreement”) with Gazellek Holdings I, LLC (“GHI
LLC”), pursuant to which GHI LLC lent $3,450,000 to the Company on August 6, 2021. The loan bears in-kind interest, quarterly,
at the annual rate of 7%, which has the effect of compounding the interest and adding it to the principal amount. The loan is secured
by substantially all of the Company’s assets and those of all of its subsidiaries, which are required to guarantee the loan, and
matures August 2, 2024.
The
Company is required to prepay the loan upon receiving proceeds from future indebtedness exceeding $5,000,000 (other than indebtedness
that is junior to the loan), or if the Company issues any capital stock (provided that the Company is allowed to retain up to 20% of
the proceeds from such issuance). The GHI Loan Agreement contains customary representations and warranties, covenants and events of default.
Upon the occurrence of an event of default, the loan bears interest at a rate 5% above the then-effective interest rate and, at GHI LLC’s
option, is payable either in cash or in cash and shares of Company common stock, valued at market, equal to up to 10% of the outstanding
principal amount of the loan. A default fee equal to 0.5% of the outstanding principal applies if any default exists for 10 days or more.
Scheduled
maturities of the Company’s long-term debt, as they exist as of March 31, 2023, in each of the next five fiscal years and thereafter
are as follows:
Schedule
of Long-term Debt Maturities
Fiscal years ending in | |
(in millions) | |
2023 | |
$ | — | |
2024 | |
| 3.8 | |
2025 | |
| — | |
2026 | |
| — | |
2027 | |
| — | |
2028 and thereafter | |
| 0.2 | |
Total | |
$ | 4.0 | |
Note
7 — Stock-Based Compensation
We
have stock-based compensation awards consisting of stock options under the 2011 Incentive Plan, which is described in detail in our Annual
Report on Form 10-K for the year ended December 31, 2022. As of March 31, 2023, there are no remaining shares available for grant under
the 2011 Incentive Plan. No further shares were available for grant under any other stock incentive plan. The Company did not have any
stock-based compensation expense for the three months ended March 31, 2023 and 2022.
Stock
Options
The
following table summarizes our stock option activity:
Summary
of Stock Option Activity
| |
Stock Options | | |
Weighted Average Exercise Price | |
Outstanding December 31, 2022 | |
| 1,360 | | |
$ | 106.00 | |
Outstanding March 31, 2023 | |
| 1,360 | | |
$ | 106.00 | |
Exercisable as of March 31, 2023 | |
| 1,360 | | |
$ | 106.00 | |
As
of March 31, 2023, options to purchase 1,360 shares are outstanding and exercisable, and the aggregate intrinsic value of all outstanding
stock options was $0.0 million. No options were granted or exercised during the three months ended March 31, 2023.
As
of March 31, 2023, there is no unrecognized compensation expense related to outstanding stock options.
Note
8 — Income Taxes
For
interim income tax reporting, we are required to estimate our annual effective tax rate and apply it to year-to-date pre-tax income (loss),
excluding unusual or infrequently occurring discrete items. For the three months ended March 31, 2023, we recorded income tax from continuing
operations of $0.0 million, on a loss of $1.1 million. For the three months ended March 31, 2022, we recorded income tax from continuing
operations of $0.0 million on a loss of $0.8 million. The effective income tax rate for the three months ended March 31, 2023 differs
from the U.S. federal statutory rate of 21% primarily due to a valuation allowance on various deferred tax assets.
We
file income tax returns in multiple jurisdictions that are subject to review by various U.S and state taxing authorities. Our U.S. federal
income tax returns for 2019 to present, and certain state returns from 2018 to present, are open to examination.
Note 9 — Shareholders’
Equity
Treasury
Stock
On
November 14, 2016, our Board authorized a share repurchase program under which we may repurchase up to 2,500 shares of common stock,
from time to time, using a variety of methods, which may include open market transactions and privately negotiated transactions.
The
Company did not purchase any shares during the three months ended March 31, 2023. Since the November 14, 2016 authorization, we have
repurchased 780 shares of common stock for $0.3 million, and, as of March 31, 2023, we had remaining authorization to repurchase 1,720
additional shares.
As
of March 31, 2023 and December 31, 2022, the Company has 2,927 shares of treasury stock, acquired at an average price of $8,496.47 per
share.
Stock
Warrants
In
connection with the GHI Loan Agreement, the Company issued to GHI LLC, for $120,000, a Common Stock Purchase Warrant entitling GHI LLC
to purchase 4.8% of GLAE’s outstanding common stock, at the price of $0.01 per share, and a second Common Stock Purchase Warrant
entitling GHI LLC to purchase 5.2% of GLAE’s outstanding common stock, at the price of $169.62 per share. The second warrant is
automatically canceled if the Company consummates a Sale Transaction that is sourced other than by GHI LLC or its affiliates. A “Sale
Transaction” is a merger, consolidation, combination or similar transaction (in one or a series of related transactions), such
that the beneficial owners of shares of Company common stock immediately prior to the transaction or transactions will, immediately after
such transaction or transactions, beneficially own less than a majority of the shares of common stock or outstanding equity of the surviving
corporation (on a fully diluted basis). Each warrant expires August 2, 2026, is exercisable net of proceeds received; entitles its holder
to receive certain distributions on the Company’s common stock, as if the warrant had been exercised; and bears registration rights
respecting the underlying common stock. The first warrant purports to give its holder voting rights, as if the warrant had been exercised.
The sale was exempt from registration under the Securities Act pursuant to Sec. 4(a)(2), as not involving any public offering, because
no general solicitation was involved, and GHI LLC is an accredited professional investor, which agreed to accept restricted securities.
See Note 6 – Debt for more information on the GHI Loan Agreement.
Note
10 — Segment Information
As
of March 31, 2023, the asset management business is our only reportable segment.
We
evaluate segment performance based on revenue and operating loss. The operating loss reported in our segments excludes corporate and
other unallocated amounts. Although such amounts are excluded from the business segment results, they are included in reported consolidated
results. The corporate and unallocated operating loss includes costs that are not allocated to the business segments in management’s
evaluation of segment performance, such as litigation settlement expense, corporate expense and other expenses.
Net
revenue, operating loss from operations and assets by segment were as follows (unaudited):
schedule
of net revenue, operating loss from operations and assets
| |
| | |
| |
| |
Three Months Ended | |
| |
March 31, | |
(In millions) | |
2023 | | |
2022 | |
Net revenue | |
| | | |
| | |
Asset management business | |
$ | 0.1 | | |
$ | — | |
Total net revenue | |
| 0.1 | | |
| — | |
Operating loss from operations | |
| | | |
| | |
Asset management business | |
| (0.3 | ) | |
| (0.4 | ) |
Total segment operating loss | |
| (0.3 | ) | |
| (0.4 | ) |
Corporate and unallocated loss | |
| (0.7 | ) | |
| (0.4 | ) |
Total operating loss | |
| (1.0 | ) | |
| (0.8 | ) |
Interest expense | |
| (0.1 | ) | |
| (0.1 | ) |
Other income, net | |
| — | | |
| 0.1 | |
| |
March 31, | | |
| |
| |
2023 | | |
December 31, | |
(In millions) | |
(unaudited) | | |
2022 | |
Assets | |
| | | |
| | |
Asset management business | |
$ | 13.8 | | |
$ | 13.5 | |
Total segment assets | |
| 13.8 | | |
| 13.5 | |
Corporate and unallocated | |
| 0.3 | | |
| 1.1 | |
Total consolidated assets | |
$ | 14.1 | | |
$ | 14.6 | |
Note
11 — Litigation, Commitments and Contingencies
Plaintiff
Cypress Holdings, III L.P. (“Cypress”) filed an action against GlassBridge Enterprises, Inc. in New York Supreme Court, which
was removed to the United States District Court, Southern District of New York, on February 14, 2022, captioned Cypress Holdings, III
L.P. v. Sport-BLX, Inc. et al., 1:22-cv-01243-LGS (S.D.N.Y.). In its Second Amended Complaint, Cypress purports to assert claims against
SportBLX, Mr. Hall, and Mr. De Perio for securities fraud and related issues and seeks compensatory damages, punitive damages and attorneys’
fees, in connection with solicitations of investments in SportBLX. Cypress also purports to allege that GlassBridge Enterprises, Inc.
is liable for unjust enrichment, tortious interference with contract, aiding and abetting a breach of fiduciary duty and minority shareholder
oppression. Cypress also purports to assert claims against Messrs. Strauss and Ruchalski for breach of fiduciary duty and corporate waste,
as well as additional claims against Clinton Group Inc., Cesar Baez, Christopher Johnson, and Sport-BLX Securities, Inc. arising from
solicitations of investments in SportBLX.
The
matter is presently in the discovery phase and GlassBridge Enterprises, Inc., and Messrs. Strauss and Ruchalski, intend to defend themselves
vigorously. As of December 31, 2021, GlassBridge Enterprises, Inc. sold all of its interest in SportBLX and SportBLX ceased to be a subsidiary.
As
of March 31, 2023, the Company believes that an outcome resulting in a loss is remote and does not have any accruals related to the matter.
Indemnification
Obligations
In
the normal course of business, we periodically enter into agreements that incorporate general indemnification language. Performance under
these indemnities would generally be triggered by a breach of terms of the contract or by a supportable third-party claim. There has
historically been no material losses related to such indemnifications. As of March 31, 2023 and December 31, 2022, estimated liability
amounts associated with such indemnifications were not material.
Note
12 — Fair Value Measurements
Fair
value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or the exit price in an orderly
transaction between market participants on the measurement date. A three-level hierarchy is used for fair value measurements based upon
the observability of the inputs to the valuation of an asset or liability as of the measurement date. Level 1 measurements consist of
unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 measurements include quoted prices in markets
that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or
liability. Level 3 measurements include significant unobservable inputs. A financial instrument’s level within the hierarchy is
based on the highest level of any input that is significant to the fair value measurement. The Company measures certain assets and liabilities
at their estimated fair value on a recurring basis, including cash and cash equivalents and investments in marketable securities.
The
following tables present investments measured at fair value:
Schedule
of Investments measured at Fair Value
| |
March 31, 2023 | |
(In millions) | |
Level 1 | | |
Level 2 | | |
Level 3 | | |
Total | |
Assets: | |
| | | |
| | | |
| | | |
| | |
Marketable securities | |
$ | 0.3 | | |
$ | — | | |
$ | — | | |
$ | 0.3 | |
| |
| December 31, 2022 | |
(In millions) | |
Level 1 | | |
Level 2 | | |
Level 3 | | |
Total | |
Assets: | |
| | | |
| | | |
| | | |
| | |
Marketable securities | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | |